Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

SELL
$7.7 - $37.13 $0 - $0
0 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$26.46 - $37.15 $0 - $0
0 New
0 $0
Q2 2021

Aug 06, 2021

BUY
$32.73 - $47.95 $0 - $0
0 New
0 $0
Q1 2021

May 14, 2021

BUY
$40.39 - $56.73 $0 - $0
0 New
0 $0
Q4 2020

Feb 12, 2021

BUY
$51.77 - $66.18 $0 - $0
0 New
0 $0
Q3 2020

Nov 12, 2020

BUY
$43.8 - $58.16 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

BUY
$37.05 - $65.03 $0 - $0
0 New
0 $0
Q1 2020

May 14, 2020

BUY
$33.63 - $69.4 $0 - $0
0 New
0 $0
Q4 2019

Feb 13, 2020

BUY
$31.7 - $69.93 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019

BUY
$19.95 - $38.85 $0 - $0
0 New
0 $0

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.